小路正博, 1996 - Google Patents
Application of AE6F4 antibody to the sputum cytodiagnosis for lung cancer小路正博, 1996
View PDF- Document ID
- 7701459317988156532
- Author
- 小路正博
- Publication year
External Links
Snippet
APPLICATION OF AE6F4 ANTIBODY TO THE SPUTUM CYTODIAGNOSIS FOR LUNG CANCER
Page 1 九州大学学術情報リポジトリ Kyushu University Institutional Repository APPLICATION
OF AE6F4 ANTIBODY TO THE SPUTUM CYTODIAGNOSIS FOR LUNG CANCER 小路, 正博 …
- 102000004965 antibodies 0 title abstract description 5
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023040115A (en) | Antibodies and assays for detecting folate receptor 1 | |
| US10202454B2 (en) | Anti-PD-L1 monoclonal antibodies and fragments thereof | |
| CA2479494C (en) | Compositions and methods associated with pro5725 and its use for the diagnosis of lung and colon tumor | |
| RU2651513C2 (en) | Novel antibody for diagnosis and/or prognosis of cancer | |
| CN101854946B (en) | Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers | |
| AU2009234389B2 (en) | Compositions and methods for detecting EGFR mutations in cancer | |
| JP2011206062A (en) | Method and composition for diagnosing carcinoma | |
| AU2007318483A1 (en) | Anti-human Dlk-1 antibody showing anti-tumor activity in vivo | |
| EP3831944A1 (en) | Anti-ror1 monoclonal antibody, functional fragment thereof, gene, drug delivery composition, and pharmaceutical composition | |
| UA75393C2 (en) | Chimeric monoclonal antibody, identifying gangliosides containing n-glycolyl sialic acid, cells line producing it and pharmaceutical compositions containing it | |
| KR20050004240A (en) | Compositions and Methods for the Treatment of Tumor | |
| US11104740B2 (en) | Antibodies and assays for detection of CD37 | |
| EP2905335B1 (en) | Anti-human dlk-1 antibody having anti-tumor activity in vivo | |
| CA2552553C (en) | Method of detecting liver cancer, diagnostic for liver cancer and remedy for cancer | |
| Babich et al. | Labyrinthin: A distinct pan-adenocarcinoma diagnostic and immunotherapeutic tumor specific antigen | |
| CN115803054A (en) | Single chain antibodies and intrabodies to misfolded TDP-43 and methods of use thereof | |
| JP2001292767A (en) | Development of dna probe and immunological reagent for antigen relating to human tumor | |
| 小路正博 | Application of AE6F4 antibody to the sputum cytodiagnosis for lung cancer | |
| CN106957367B (en) | anti-IDH 1R132H antibody and preparation method and application thereof | |
| CN114213542B (en) | CPS-I antibodies and uses thereof | |
| JP4712692B2 (en) | Novel polypeptides useful in cancer diagnosis and treatment | |
| CN102617710B (en) | New immune epitope for specific antibody of human new gene FAMLF, and preparation and application of antibody | |
| CN108727496A (en) | The anti-human p63 protein monoclonal antibodies of mouse prepare and its immunohistochemistry purposes | |
| KR20040077787A (en) | Compositions and Methods for the Treatment of Tumor | |
| AU2014265106A1 (en) | Compositions and methods for detecting EGFR mutations in cancer |